Digoxin Toxicity: Stratification and Evidence-Based Decision Making for Emergency Medicine Pharmacists
Despite its declining use, digoxin toxicity remains a high-risk clinical challenge encountered in the emergency department, particularly among older adults and patients with renal dysfunction, electrolyte abnormalities, or significant drug interactions. This webinar, sponsored by the Academy of Emergency Medicine Pharmacists (AEMP), reviews the recognition, risk stratification, and evidence-based management of acute and chronic digoxin toxicity, with a focus on practical decision-making for emergency medicine pharmacists. Viewers will learn how to identify patients at risk, interpret clinical and laboratory findings, determine appropriate use of digoxin immune Fab, and optimize interdisciplinary management to improve patient outcomes.
Learning Objectives
At the completion of this activity, the pharmacist will be able to:
- Identify patients at risk for acute and chronic digoxin toxicity.
- Apply evidence-based recommendations for the management and treatment of digoxin toxicity.
- Apply interdisciplinary communication strategies during the management of a patient with suspected digoxin toxicity in the emergency department.